Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Loidi JC, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios Jefe J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Salinas NE, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Rosso RG, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Robles EM, Matteelli A, Mazza-Stalder J, Moschos C, Munoz-Torrico M, Hamdan HM, Nakčerienė B, Nicod L, Marcos MN, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB.

Eur Respir J. 2019 Oct 10. pii: 1901522. doi: 10.1183/13993003.01522-2019. [Epub ahead of print]

PMID:
31601711
2.

Tuberculosis among asylum-seekers in Milan, Italy: Epidemiological analysis and evaluation of interventions.

Villa S, Codecasa LR, Faccini M, Pontello MM, Ferrarese M, Castellotti PF, Senatore S, Lamberti A, Mazzola E, Perno CF, Campisi D, Saporiti M, Raviglione MC.

Eur Respir J. 2019 Aug 14. pii: 1900896. doi: 10.1183/13993003.00896-2019. [Epub ahead of print]

PMID:
31413161
3.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

4.

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection.

Petruccioli E, Chiacchio T, Vanini V, Cuzzi G, Codecasa LR, Ferrarese M, Schininà V, Palmieri F, Ippolito G, Goletti D.

Sci Rep. 2018 Oct 23;8(1):15626. doi: 10.1038/s41598-018-33825-w.

5.

Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan.

Barcellini L, Campisi D, Castellotti PF, Cugnata F, Ferrara G, Ferrarese M, Murgia N, Repossi A, Cirillo DM, Codecasa LR.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1160-1165. doi: 10.5588/ijtld.18.0114.

PMID:
30236183
6.

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.

PMID:
30216086
7.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

8.

Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.

Larsson LO, Polverino E, Hoefsloot W, Codecasa LR, Diel R, Jenkins SG, Loebinger MR.

Expert Rev Respir Med. 2017 Dec;11(12):977-989. doi: 10.1080/17476348.2017.1386563. Epub 2017 Oct 10. Review.

PMID:
28967797
9.

Long-lasting tuberculous pleurisy.

Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Codecasa LR, Ottenhoff TH, Denkinger CM, Goletti D.

Eur Respir J. 2017 May 25;49(5). pii: 1700356. doi: 10.1183/13993003.00356-2017. Print 2017 May. No abstract available.

10.

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.

Codecasa LR, Toumi M, D'Ausilio A, Aiello A, Damele F, Termini R, Uglietti A, Hettle R, Graziano G, De Lorenzo S.

J Mark Access Health Policy. 2017 Feb 17;5(1):1283105. doi: 10.1080/20016689.2017.1283105. eCollection 2017.

11.

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM.

Eur Respir J. 2016 Nov;48(5):1411-1419. doi: 10.1183/13993003.00510-2016. Epub 2016 Jul 7.

12.

Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.

Bothamley GH, Ehlers C, Salonka I, Skrahina A, Orcau A, Codecasa LR, Ferrarese M, Pesut D, Solovic I, Dudnyk A, Anibarro L, Denkinger C, Guglielmetti L, Muylle I, Confalonieri M.

BMC Pregnancy Childbirth. 2016 Oct 12;16(1):304.

13.

Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

Schepisi MS, Gualano G, Piselli P, Mazza M, D'Angelo D, Fasciani F, Barbieri A, Rocca G, Gnolfo F, Olivani P, Ferrarese M, Codecasa LR, Palmieri F, Girardi E.

Infect Dis Rep. 2016 Jun 24;8(2):6594. doi: 10.4081/idr.2016.6594. eCollection 2016 Jun 24.

14.

The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection.

Esposito S, Codecasa LR, Centis R.

Eur Respir J. 2015 Feb;45(2):571-4. doi: 10.1183/09031936.00157914. No abstract available.

15.

Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country.

Faccini M, Cantoni S, Ciconali G, Filipponi MT, Mainardi G, Marino AF, Senatore S, Codecasa LR, Ferrarese M, Gesu G, Mazzola E, Filia A.

Epidemiol Infect. 2015 Oct;143(13):2841-8. doi: 10.1017/S095026881400394X. Epub 2015 Jan 20.

PMID:
25600903
16.

Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal.

Codecasa LR, Ciconali G, Mazzola E, Ferrarese M, Cirillo D, Borroni E, Gesu GP, Zellweger JP, Centis R, Faccini M.

Eur Respir J. 2015 Jan;45(1):292-4. doi: 10.1183/09031936.00134114. No abstract available.

17.

Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis.

Norbis L, Alagna R, Tortoli E, Codecasa LR, Migliori GB, Cirillo DM.

Expert Rev Anti Infect Ther. 2014 May;12(5):633-47. doi: 10.1586/14787210.2014.899900. Epub 2014 Mar 20. Review.

PMID:
24717112
18.

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement.

van Hest NA, Aldridge RW, de Vries G, Sandgren A, Hauer B, Hayward A, Arrazola de Oñate W, Haas W, Codecasa LR, Caylà JA, Story A, Antoine D, Gori A, Quabeck L, Jonsson J, Wanlin M, Orcau Å, Rodes A, Dedicoat M, Antoun F, van Deutekom H, Keizer S, Abubakar I.

Euro Surveill. 2014 Mar 6;19(9). pii: 20728.

19.

The spread of drug-resistant tuberculosis in children: an Italian case series.

Mignone F, Codecasa LR, Scolfaro C, Raffaldi I, Lancella L, Ferrarese M, Garazzino S, Marabotto C, Esposito S, Gabiano C, Lipreri R, Tovo PA.

Epidemiol Infect. 2014 Oct;142(10):2049-56. doi: 10.1017/S0950268813003191. Epub 2013 Dec 19.

PMID:
24480079
20.

miRNA signatures in sera of patients with active pulmonary tuberculosis.

Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, Ambrosi A, Codecasa LR, Goletti D, Matteelli A, Ntinginya EN, Aloi F, Heinrich N, Reither K, Cirillo DM.

PLoS One. 2013 Nov 21;8(11):e80149. doi: 10.1371/journal.pone.0080149. eCollection 2013.

21.

Isoniazid preventive treatment: predictors of adverse events and treatment completion.

Codecasa LR, Murgia N, Ferrarese M, Delmastro M, Repossi AC, Casali L, Besozzi G, Ferrara G, Raviglione MC.

Int J Tuberc Lung Dis. 2013 Jul;17(7):903-8. doi: 10.5588/ijtld.12.0677. Epub 2013 May 3.

PMID:
23651743
22.

Tuberculosis outbreak in a primary school, Milan, Italy.

Faccini M, Codecasa LR, Ciconali G, Cammarata S, Borriello CR, De Gioia C, Za A, Marino AF, Vighi V, Ferrarese M, Gesu G, Mazzola E, Castaldi S.

Emerg Infect Dis. 2013 Mar;19(3):485-7. doi: 10.3201/eid1902.120527.

23.

[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers].

Murgia N, Ferrara G, Muzi G, Ferrarese M, Abbritti G, Codecasa LR.

G Ital Med Lav Ergon. 2011 Jul-Sep;33(3 Suppl):157-8. Italian.

PMID:
23393826
24.

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group.

Eur Respir J. 2008 Apr;31(4):904-5. doi: 10.1183/09031936.00159807. No abstract available.

25.

Clinical and operational value of the extensively drug-resistant tuberculosis definition.

Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group.

Eur Respir J. 2007 Oct;30(4):623-6. Epub 2007 Aug 9.

26.

Ripped from the headlines: how can we harness communications to control TB?

Migliori GB, Cirillo DM, Spanevello A, Codecasa LR; Stop TB Italia Group.

Eur Respir J. 2007 Aug;30(2):194-8. No abstract available.

27.

Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients.

Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM.

Eur Respir J. 2006 Jul;28(1):31-4. Epub 2006 Mar 15.

28.

Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs.

Codecasa LR, Ferrara G, Ferrarese M, Morandi MA, Penati V, Lacchini C, Vaccarino P, Migliori GB.

Respir Med. 2006 Sep;100(9):1566-72. Epub 2006 Feb 15.

29.

Incidence of venous thromboembolism in tuberculosis patients.

Ambrosetti M, Ferrarese M, Codecasa LR, Besozzi G, Sarassi A, Viggiani P, Migliori GB; AIPO/SMIRA TB Study Group.

Respiration. 2006;73(3):396. Epub 2004 May 28. No abstract available.

PMID:
16439829
30.

Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis.

Piana F, Codecasa LR, Besozzi G, Migliori GB, Cirillo DM.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):130; author reply 130-1. No abstract available.

PMID:
16368794
31.

Comparison of tuberculin skin test and Quantiferon immunological assay for latent tuberculosis infection.

Codecasa LR, Ferrarese M, Penati V, Lacchini C, Cirillo D, Scarparo C, Piccoli P, Piersimoni C, Migliori GB.

Monaldi Arch Chest Dis. 2005 Sep;63(3):158-62.

PMID:
16312206
32.

Management of multidrug-resistant tuberculosis in Italy.

Ferrara G, Richeldi L, Bugiani M, Cirillo D, Besozzi G, Nutini S, Casali L, Fiorentini F, Codecasa LR, Migliori GB.

Int J Tuberc Lung Dis. 2005 May;9(5):507-13.

PMID:
15875921
33.

Epidemiology and control of tuberculosis in Western European cities.

Codecasa LR, Besozzi G, Penati V, Migliori GB.

Int J Tuberc Lung Dis. 2004 Oct;8(10):1275-6. No abstract available.

PMID:
15527165
34.

Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.

Migliori GB, Fattorini L, Vaccarino P, Besozzi G, Saltini C, Orefici G, Iona E, Matteelli A, Fiorentini F, Codecasa LR, Casali L, Cassone A; SMIRA (Italian Multicentre Study on Resistance to Anti-tuberculosis drugs) Study Group.

Int J Tuberc Lung Dis. 2002 Jan;6(1):32-8.

PMID:
11931399
35.

Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in Italy.

Migliori GB, Ambrosetti M, Besozzi G, Farris B, Nutini S, Saini L, Confalonieri M, Bugiani M, Codecasa LR; National AIPO 'Tuberculosis' Study Group.

Eur J Epidemiol. 2000;16(8):719-24.

PMID:
11142499
36.

The Italian AIPO study on tuberculosis treatment results, report 1997. National AIPO "Tuberculosis" Study Group.

Ambrosetti M, Besozzi G, Codecasa LR, Farris B, Nutini S, Saini L, Casali L, Nardini S, Migliori GB.

Monaldi Arch Chest Dis. 1999 Oct;54(5):407-12.

PMID:
10741100
37.
38.

Hospital admission policy for tuberculosis in pulmonary centres in Italy: a national survey. AIPO Tuberculosis Study Group. Italian Association of Hospital Pulmonologists.

Nutini S, Fiorenti F, Codecasa LR, Casali L, Besozzi G, Di Pisa G, Nardini S, Migliori GB.

Int J Tuberc Lung Dis. 1999 Nov;3(11):985-91.

PMID:
10587320
39.

Tuberculosis among immigrants from developing countries in the province of Milan, 1993-1996.

Codecasa LR, Porretta AD, Gori A, Franzetti F, Degli Esposti A, Lizioli A, Carreri V, Di Proietto MC, Perozziello F, Besozzi G.

Int J Tuberc Lung Dis. 1999 Jul;3(7):589-95.

PMID:
10423221
40.

The Italian AIPO study on tuberculosis treatment results, report 1995. National AIPO "Tuberculosis" Study Group.

Ambrosetti M, Besozzi G, Codecasa LR, Farris B, Nutini S, Saini L, Casali L, Nardini S, Migliori GB.

Monaldi Arch Chest Dis. 1999 Feb;54(1):49-54.

PMID:
10218371
41.

Epidemiological and clinical patterns of intrathoracic lymph node tuberculosis in 60 human immunodeficiency virus-negative adult patients.

Codecasa LR, Besozzi G, De Cristofaro L, Miradoli A, Sabolla L, Tagliaferri B.

Monaldi Arch Chest Dis. 1998 Jun;53(3):277-80.

PMID:
9785811
42.
43.

Clinical reliability of diagnostic tests in allergic rhinoconjunctivitis.

Pastorello EA, Codecasa LR, Pravettoni V, Qualizza R, Incorvaia C, Ispano M, Stocchi L, Guidoboni A, Zanussi C.

Boll Ist Sieroter Milan. 1988;67(5-6):377-85.

PMID:
3154983
44.

IgG subclass antibody response to hymenoptera venom.

Pastorello EA, Incorvaia C, Vassellatti D, Qualizza R, Codecasa LR.

N Engl Reg Allergy Proc. 1987 Nov-Dec;8(6):437-41. Review.

PMID:
3325820
45.

The role of suggestion in asthma. II. Effects of a bronchoconstrictor drug on bronchial reactivity under bronchoconstrictor or bronchodilator suggestion.

Pastorello EA, Codecasa LR, Gerosa A, Buonocore E, Sillano V, Zanussi C.

Ann Allergy. 1987 Nov;59(5):339-40.

PMID:
3318573
46.

The role of suggestion in asthma. I. Effects of inactive solution on bronchial reactivity under bronchoconstrictor or bronchodilator suggestion.

Pastorello EA, Codecasa LR, Pravettoni V, Zara C, Incorvaia C, Froldi M, Zanussi C.

Ann Allergy. 1987 Nov;59(5):336-8.

PMID:
3318572
47.

Antihistaminic treatment of allergic rhinitis: a double-blind study with terfenadine versus dexchlorpheniramine.

Pastorello EA, Ortolani C, Gerosa S, Pravettoni V, Codecasa LR, Fugazza A, Zanussi C.

Pharmatherapeutica. 1987;5(2):69-75.

PMID:
2889217

Supplemental Content

Loading ...
Support Center